pdf | | 2017-05-22 | Author:Gorczyca, Wojciech

pdf | | 0101-01-01 | Author:Won Jun Kang & Seong Rok Huh & Byung-Sik Park & Dong-ho Lee & Keun-Byoung Yoon

pdf | | | Author:unknow

epub |eng | | Author:Andreas Zirlik, Christoph Bode & Meinrad Gawaz

20. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood. 1997;89:101–7.PubMed 21. Murphy ...

epub |eng | | Author:Saad Z. Usmani & Ajay K. Nooka

5.9.1.2 Carfilzomib, Cyclophosphamide, and Dexamethasone (CCyD) Carfilzomib has also been combined with cyclophosphamide and dexamethasone as a treatment regimen in a phase II study newly diagnosed patients who were not ...

epub |eng | | Author:Meletios A. Dimopoulos, Thierry Facon & Evangelos Terpos

Patients with Asymptomatic Myeloma (AMM) Intravenous PAM (60–90 mg monthly for 12 months) in patients with AMM reduced bone involvement at progression but did not decrease the risk and increase ...

epub |eng | | Author:Paul Imbach, Thomas Kühne & Robert J. Arceci

Radiotherapy:In radical resection of tumor, 40–50 Gy, but higher doses with hyperfractionation High rate of morbidity Chemotherapy:Only in exceptional situations, depending on the tumor type (diffuse infiltrating character) Effective drugs ...

epub |eng | | Author:Joe F. Lau, Geoffrey D. Barnes & Michael B. Streiff

Oral Direct Thrombin Inhibitors Ximelagatran The first oral direct thrombin inhibitor, ximelagatran (Exanta®, AstraZeneca), studied in a fixed dose in the international SPORTIF trials, proved non-inferior to warfarin for prevention ...

epub |eng | | Author:Oussama Abla & Gritta Janka

Syntaxin 11 Deficiency Causes FHL4 In patients with FHL4 (MIM 605014), the mean time of HLH onset is later than in patients with FHL2 or FHL3 [36, 37]. FHL4 Patients ...

epub |eng | | Author:Antonio M. Esquinas, S. Egbert Pravinkumar & AYMAN O. SOUBANI

18.4 CPAP for Immunosuppressed Patients With the increased number of immunosuppressed patients, respiratory complications are the main contributor to mortality [25] and often require invasive mechanical ventilation which is associated ...

epub, pdf |eng | | Author:Theresa Nester

Do You Agree or Disagree with the Management? I agree with the product selection ; I disagree with issuing the units in a single cooler. Issuing the blood for two ...

epub |eng | | Author:Miguel-Angel Perales & Syed A. Abutalib & Catherine Bollard

8.7 Generation of Virus-Specific T Cells from Virus-Naïve Donors Initially, the generation of donor-derived virus-specific T cells had a prerequisite that the donor should be seropositive for the relevant virus ...

epub |eng | | Author:Prabhjot Kaur

Soon it was realized that antigen-binding site restrictions were not specific to IGHV3-21-expressing CLL but involved most of the CLL IG repertoire. Several studies show the presence of “stereotyped” Vh ...

epub |eng | | Author:Éliane Gluckman, Dietger Niederwieser & Mahmoud Aljurf

Personal History and Physical Examination Personal history includes questions on general health, and past and current health disorders, including a past history of hematological, immunological, or malignant disease. Smoking and ...

epub |eng | | Author:Richard T. T. Maziarz & Susan Slater

c.If patient is sulfa-allergic, alternative therapies include pentamidine 4 mg/kg/day IV (need to renal dose adjust with abnormal renal function) for 21 days (for severe disease) or clindamycin 450 mg ...